These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19717314

  • 1. Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
    Nicolau-Raducu R, Subramaniam K, Marquez J, Wells C, Hilmi I, Sullivan E.
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):73-9. PubMed ID: 19717314
    [Abstract] [Full Text] [Related]

  • 2. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 3. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.
    Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626
    [Abstract] [Full Text] [Related]

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 01; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 5. Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: definition, incidence, and clinical predictors.
    Augoustides JG, Pochettino A, Ochroch EA, Cowie D, Weiner J, Gambone AJ, Pinchasik D, Bavaria JE, Jobes DR.
    J Cardiothorac Vasc Anesth; 2006 Oct 01; 20(5):673-7. PubMed ID: 17023287
    [Abstract] [Full Text] [Related]

  • 6. The effects of aprotinin on blood product transfusion associated with thoracic aortic surgery requiring deep hypothermic circulatory arrest.
    Seigne PW, Shorten GD, Johnson RG, Comunale ME.
    J Cardiothorac Vasc Anesth; 2000 Dec 01; 14(6):676-81. PubMed ID: 11139108
    [Abstract] [Full Text] [Related]

  • 7. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug 01; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 8. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM.
    Transfusion; 2006 Mar 01; 46(3):327-38. PubMed ID: 16533273
    [Abstract] [Full Text] [Related]

  • 9. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O.
    J Thorac Cardiovasc Surg; 2000 Sep 01; 120(3):520-7. PubMed ID: 10962414
    [Abstract] [Full Text] [Related]

  • 10. Aprotinin use with hypothermic circulatory arrest for aortic valve and thoracic aortic surgery: renal function and early survival.
    Regragui IA, Bryan AJ, Izzat MB, Wisheart JD, Hutter JA, Angelini GD.
    J Heart Valve Dis; 1995 Nov 01; 4(6):674-7. PubMed ID: 8611985
    [Abstract] [Full Text] [Related]

  • 11. Major clinical outcomes in adults undergoing thoracic aortic surgery requiring deep hypothermic circulatory arrest: quantification of organ-based perioperative outcome and detection of opportunities for perioperative intervention.
    Augoustides JG, Floyd TF, McGarvey ML, Ochroch EA, Pochettino A, Fulford S, Gambone AJ, Weiner J, Raman S, Savino JS, Bavaria JE, Jobes DR.
    J Cardiothorac Vasc Anesth; 2005 Aug 01; 19(4):446-52. PubMed ID: 16085248
    [Abstract] [Full Text] [Related]

  • 12. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M, Selkane C, Amahzoune B, El Bekkali Y, Wahid FA, Moutaki Allah Y, Boulahya A, Ibat D, Drissi M, Azendour H, Elkirat A.
    Ann Cardiol Angeiol (Paris); 2007 Dec 01; 56(6):308-12. PubMed ID: 17976511
    [Abstract] [Full Text] [Related]

  • 13. Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: a risk factor analysis for adverse outcome in 501 patients.
    Khaladj N, Shrestha M, Meck S, Peterss S, Kamiya H, Kallenbach K, Winterhalter M, Hoy L, Haverich A, Hagl C.
    J Thorac Cardiovasc Surg; 2008 Apr 01; 135(4):908-14. PubMed ID: 18374779
    [Abstract] [Full Text] [Related]

  • 14. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
    Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, Tanaka KA.
    J Cardiothorac Vasc Anesth; 2010 Dec 01; 24(6):959-63. PubMed ID: 20430647
    [Abstract] [Full Text] [Related]

  • 15. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P.
    Eur J Cardiothorac Surg; 2009 Jan 01; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [Abstract] [Full Text] [Related]

  • 16. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, Mehlhorn U.
    Curr Med Res Opin; 2004 Jan 01; 20(1):121-6. PubMed ID: 14741082
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR, Dryden PJ, O'Connor JP, Sadeghi H, Ansley DM, Merrick PM.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [Abstract] [Full Text] [Related]

  • 18. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G, Sartipy U, Ivert T, van der Linden J.
    Ann Thorac Surg; 2008 Jul 04; 86(1):13-9. PubMed ID: 18573391
    [Abstract] [Full Text] [Related]

  • 19. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O.
    Paediatr Anaesth; 2005 Jan 04; 15(1):41-6. PubMed ID: 15649162
    [Abstract] [Full Text] [Related]

  • 20. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL, Stahl RF, Roslund BP, Roke-Thomas M.
    Pharmacotherapy; 2007 Jul 04; 27(7):988-94. PubMed ID: 17594204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.